CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to NVSEF

TOUR006 - 20 MG

Phase 2
NOVARTIS AG (NVSEF)

Phase 2

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Sep '26
NVSEFPhase 2

TOUR006 - 20 MG Phase 2 Est. Readout

TOUR006 - 20 MG
Sep 2026~
CT.gov
00%
Competitive Landscape

0 competitors in Thyroid Eye Disease

View Full Landscape
Drug Information

Target Indication

Thyroid Eye Disease

Clinical Trial

NCT06088979

Last updated: 7/14/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.